We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A 12 well plate containing red media.
Product News

Proteintech Genomics Launches First Commercially Available Solution for the Detection of Intracellular Proteins for Single-Cell RNAseq Experiments

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail.
A lab worker pipetting into a plate.
Product News

Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster, Easier, and More Efficient

Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit.
Cells.
Product News

Laverock Therapeutics Secures Innovate UK Award To Advance Immune Effector Cell Therapeutics Programme

Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.
The Biomek i7 Automated Liquid Handler.
Product News

Beckman Coulter Life Sciences and 10x Genomics Partner To Enable Single Cell Workflow Automation

Beckman Coulter Life Sciences, and 10x Genomics, Inc. (Nasdaq: TXG), announced a new partnership to expand automation solutions for single cell assay workflows.
A frozen Eppendorf tube held with tweezers.
Product News

Modelling Enables Breakthroughs in Neuromuscular Disease Research

A team of scientists have developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).
A scientist holding a rack of biosamples.
Product News

Cytiva and RoosterBio Collaborate To Address Exosome Manufacturing Challenges

Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities.
Advertisement